{"product_id":"wegovy-semaglutida-flex-touch-solucion-0-25mg-dosis-con-1","title":"Wegovy (Semaglutide) FlexTouch Solution 0.25mg\/dose Pen with 1.5ml","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eMedication\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eAntidiabetics\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eWegovy\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eSemaglutide\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e0.25 mg\/dose solution in FlexTouch device\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eNovo Nordisk\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eWegovy is indicated as an adjunct to a low-calorie diet and increased physical activity for weight management in adults with obesity (body mass index [BMI] ≥30 kg\/m²) or overweight (BMI ≥27 kg\/m²) who have at least one weight-related comorbidity. Its use is recommended in patients who have not achieved adequate weight reduction through diet and exercise alone. Additionally, Wegovy can help control blood glucose in adults with type 2 diabetes, in combination with other oral antidiabetics or insulin, when adequate control is not achieved with these treatments.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach ml of Wegovy contains 1.0 mg of Semaglutide. Excipients are: water for injection, sodium chloride, disodium phosphate, hydrochloric acid and\/or sodium hydroxide for pH adjustment.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eWegovy is contraindicated in patients with a history of hypersensitivity to Semaglutide or to any of the excipients in the formulation. Its use is not recommended in patients with a history of pancreatitis or in those with certain types of cancer, such as medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised in patients with a history of gastrointestinal disease, as Wegovy may cause adverse effects in this system. Likewise, renal function should be monitored, as alterations may occur. The use of Wegovy is not recommended in pregnant or breastfeeding women.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore refrigerated between 2 °C and 8 °C. Do not freeze. Keep out of reach of children.\u003c\/p\u003e\n\n\u003cp\u003ePrescription is required for purchase.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Novo Nordisk","offers":[{"title":"Default Title","offer_id":46313589801185,"sku":"7503007822949","price":3754.71,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/optimized_wegovy_semaglutida_flex_touch_solucion_025mgdosis_pluma_con_15ml_7503007822949_1.jpg?v=1768503942","url":"https:\/\/wecarepharma.mx\/en\/products\/wegovy-semaglutida-flex-touch-solucion-0-25mg-dosis-con-1","provider":"WeCare Pharma","version":"1.0","type":"link"}